Skip to Content

Join the 'High Cholesterol' group to help and get support from people like you.

High Cholesterol News

Related terms: Cholesteremia, Cholesterol, Elevated Levels, Cholesterol, High, Cholesterolemia, Familial Hypercholesterolemia, Hypercholesterolemia, Hypercholesterolemia, Familial, Hyperlipidemia, Lipid Metabolism Disorders

Not All Trans Fats Harm the Heart, German Study Contends

Posted 15 days ago by

TUESDAY, Sept. 22, 2015 – For years, trans fats have been viewed as bad for the heart, prompting the U.S. Food and Drug Administration last summer to ban artificial trans fats from food products. But a new study suggests that not all trans fats are equal, and some might even be good for you. The German researchers found that naturally occurring trans fats found in dairy and meat products might actually help protect the heart, while low levels of artificial trans fats did not seem to pose a health risk. "We now show that, at these low levels, industrially produced trans fats are not hazardous to health," said senior study author Clemens von Schacky, head of preventive cardiology at the University of Munich. "Come to think of it, it is a fairly common phenomenon: Some things are toxic at high levels, but we can live with them at low levels." The findings were published in the Sept. 23 ... Read more

Related support groups: Obesity, Weight Loss, High Cholesterol, Hypertriglyceridemia, Hyperlipoproteinemia, Fat Supplement, Microlipid

Could a Texting App Help Your Heart?

Posted 15 days ago by

TUESDAY, Sept. 22, 2015 – Regular text message reminders can help people with heart disease stick to a healthier lifestyle, Australian researchers report. Patients who received automated text messages throughout their week saw improvements in their "bad" LDL cholesterol levels, blood pressure and weight, the study found. The text messages even helped many quit smoking, the researchers added. The clinical trial provides some of the first evidence that simple, low-cost mobile communications programs and apps can help people adopt healthier habits, said study author Clara Chow, an associate professor at the University of Sydney Medical School and acting director of the cardiovascular division at the George Institute for Global Health. "In our fast-paced society, patients are leaving hospitals so quickly now after suffering a heart attack. They are given so much information in hospital, ... Read more

Related support groups: High Blood Pressure, Obesity, Hypertension, High Cholesterol, Hypertriglyceridemia, Cardiovascular Risk Reduction, Hyperlipoproteinemia, Hypertensive Heart Disease

Researchers Pinpoint Genes Linked to Height, Heart Disease

Posted 20 days ago by

THURSDAY, Sept. 17, 2015 – Scientists report they have identified new genes associated with height, heart disease risk and regulation of the protein in red blood cells that carries oxygen. Scientists made the discoveries using advanced whole-genome sequencing technology. Their results were published online Sept. 14 in the journal Nature Genetics. The SardiNIA study, which began in 2001, is a partnership between the U.S. National Institute on Aging, the Institute of Genetic and Biomedical Research of the Italian Research Council and the University of Michigan, Ann Arbor. The goal of the research is to pinpoint genes associated with diseases and other traits. Originally, the study examined about 2.5 million common genetic variants. But advances in sequencing technology enabled the researchers to analyze more than 17 million gene variants and their association with various health issues. ... Read more

Related support groups: Heart Disease, High Cholesterol, Cardiovascular Risk Reduction, Diagnosis and Investigation, Ischemic Heart Disease

Gut Bugs May Affect Body Fat, 'Good' Cholesterol Levels

Posted 10 Sep 2015 by

THURSDAY, Sept. 10, 2015 – The size of your waistline may depend to some degree on the specific bacteria dwelling within your gut, new research suggests. The study, of nearly 900 Dutch adults, found that certain gut bacteria might help determine not only body fat levels, but also blood concentrations of HDL cholesterol and triglycerides. HDL is the "good" cholesterol that helps maintain a healthy heart; triglycerides are another type of blood fat that, in excess, can contribute to heart disease. This is the first study to offer "solid evidence" that gut bacteria are linked to cholesterol and triglyceride levels, said lead researcher Jingyuan Fu. But it does not prove that the bacteria directly alter people's blood fats, stressed Fu, an associate professor of genetics at University Medical Center Groningen, in the Netherlands. So it's too early to recommend probiotic supplements for ... Read more

Related support groups: Obesity, High Cholesterol, Acidophilus, Hypertriglyceridemia, Florastor, Flora-Q, Floranex, Lactobacillus Acidophilus, Bacid, Saccharomyces Boulardii Lyo, Bio-K+, Florajen, Florajen3, Flora-Q 2, Provella, BioGaia, Bio-K+ Regular, Major Brewers Yeast, Lactobacillus Acidophilus/lactobacillus Casei/lactobacillus Rhamnosus, Culturelle DS

Obamacare Likely to Spur Rise in Chronic Disease Diagnoses: Study

Posted 9 Sep 2015 by

WEDNESDAY, Sept. 9, 2015 – More Americans are getting health insurance as a result of the Affordable Care Act (ACA), which may lead to many more people getting diagnosed and treated for chronic conditions, such as diabetes, a new study contends. If the number of Americans without health insurance is cut in half under the ACA, commonly called Obamacare, that likely means up to 1.5 million newly insured people will be diagnosed with one or more chronic illnesses, the researchers projected. That could help approximately 659,000 people gain control of a previously unmanaged condition, the study authors suggested. "These effects constitute a major positive outcome from the ACA," the study's senior author, Joshua Salomon, professor of global health at the Harvard T.H. Chan School of Public Health in Boston, said in a school news release. "Our study suggests that insurance expansion is likely ... Read more

Related support groups: Diabetes, Type 2, High Cholesterol

Younger Women With Diabetes More Vulnerable to Heart Attack: Study

Posted 2 Sep 2015 by

WEDNESDAY, Sept. 2, 2015 – Young women with diabetes are much more likely to have a heart attack than those without the blood sugar disease, new research says. The study from Poland also found that young women who actually had a heart attack were more likely to be smokers than older women who had suffered heart attacks. To reach these conclusions, the researchers looked at nearly 7,400 Polish women. Among those aged 45 and younger, women with diabetes were six times more likely to have a heart attack than those without diabetes. High blood pressure increased the risk by four times, high cholesterol levels tripled the risk and smoking nearly doubled the risk. There was no significant link between obesity and heart attack risk, but this may be due to the fact that diabetes was so common among obese young women, according to study co-author Hanna Szwed, a professor at the Institute of ... Read more

Related support groups: Obesity, Heart Attack, High Cholesterol, Diabetes, Type 1, Myocardial Infarction, Diabetes Mellitus, Myocardial Infarction - Prophylaxis

FDA Approves Repatha for High Cholesterol

Posted 31 Aug 2015 by

FRIDAY, Aug. 28, 2015 – Repatha (evolocumab) has been approved by the U.S. Food and Drug Administration, the second non-statin drug in its class approved to treat high cholesterol. The injected drug, among a new class called PCSK9 inhibitors, is sanctioned for people who are unable to reduce levels of the so-called LDL "bad" cholesterol with statin therapy and exercise, the agency said in a news release. Low-density lipoprotein, commonly known as LDL, builds up in the blood from natural and food sources, and is a leading cause of heart disease. About one in four deaths in the United States is linked to heart disease, making it the top cause of death among men and women. The condition kills about 610,000 people in the United States annually, the FDA said. Repatha is an antibody that targets the PCSK9 protein, which inhibits the liver's ability to remove LDL from the blood. Its most ... Read more

Related support groups: High Cholesterol, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Evolocumab, Repatha

FDA Approves Repatha - Second Drug in New Class of Cholesterol-Lowering Medications

Posted 31 Aug 2015 by

THURSDAY, Aug. 27, 2015 – The U.S. Food and Drug Administration on Thursday approved a second drug that's part of a potent new class of medications that sharply cut levels of "bad" LDL cholesterol. Repatha (evolocumab), an injectable drug, works by blocking a protein that interferes with the liver's ability to remove LDL cholesterol from the blood. In July, the FDA approved Praluent (alirocumab), another injectable drug in the same class of medications as Repatha. Both drugs are called PCSK9 inhibitors, which don't seem to cause the muscle problems that cholesterol-lowering statin drugs sometimes can. "Repatha provides another treatment option in this new class of drugs for patients with familial hypercholesterolemia or with known cardiovascular disease who have not been able to lower their LDL cholesterol enough with statins," said Dr. John Jenkins, director of the FDA's Office of New ... Read more

Related support groups: High Cholesterol, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Evolocumab, Repatha

FDA Approves Repatha (evolocumab) to Treat Certain Patients with High Cholesterol

Posted 31 Aug 2015 by

August 27, 2015 – The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options. Repatha, the second drug approved in a new class of drugs known as PCSK9 inhibitors, is approved for use in addition to diet and maximally-tolerated statin therapy in adult patients with heterozygous familial hypercholesterolemia (HeFH), homozygous familial hypercholesterolemia (HoFH), or clinical atherosclerotic cardiovascular disease, such as heart attacks or strokes, who require additional lowering of LDL cholesterol. Familial hypercholesterolemia (encompassing both HeFH and HoFH) is an inherited condition that causes high levels of LDL cholesterol. A high level of LDL cholesterol in the blood is linked to cardiovascular or heart disease. Heart ... Read more

Related support groups: High Cholesterol, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Evolocumab, Repatha

Sharp Spike Seen in Statin Use in Elderly Without Heart Disease

Posted 24 Aug 2015 by

MONDAY, Aug. 24, 2015 – There has been a sharp rise in the use of cholesterol-lowering statins among elderly patients who do not have heart disease, a new study finds. But there is little research to guide the use of these medicines in this group of patients, the investigators added. In the study, researchers analyzed data from more than 13,000 people who took part in an annual national survey between 1999 and 2012. "We found high rates of statin use in primary prevention among patients older than 79 years old who didn't have vascular disease," lead investigator Dr. Michael Johansen, a family medicine physician at Ohio State University's Wexner Medical Center, said in a university news release. Rates of heart disease among the very elderly people rose from about 28 percent in 1999-2000 to nearly 44 percent in 2011-12, but this increase was believed to be related to survey methods. Over ... Read more

Related support groups: High Cholesterol, Lipitor, Simvastatin, Crestor, Pravastatin, Atorvastatin, Zocor, Lovastatin, Rosuvastatin, Hypertriglyceridemia, Pravachol, Red Yeast Rice, Livalo, Cardiovascular Risk Reduction, Hyperlipoproteinemia, Lescol, Lescol XL, Mevacor, Altoprev, Pitavastatin

Vitamin D Supplements Little Help for Obese Teens, Study Finds

Posted 14 Aug 2015 by

FRIDAY, Aug. 14, 2015 – Taking vitamin D supplements does not benefit obese teens and may actually harm their health, new research indicates. Studies have suggested a link between vitamin D deficiency and problems such as insulin resistance and heart disease, and some doctors put obese teens on high-dose vitamin D supplementation to try to slow or reverse such obesity-related health problems. But this latest research found the supplements do not improve obese teens' heart health or reduce their diabetes risk, said Dr. Seema Kumar, a pediatric endocrinologist at the Mayo Clinic Children's Center in Rochester, Minn. In addition, the supplements may be linked to increased levels of cholesterol and fat-storing triglycerides, according to a Mayo Clinic news release. "After three months of having vitamin D boosted into the normal range with supplements, these teenagers showed no changes in ... Read more

Related support groups: Obesity, Weight Loss, High Cholesterol, Caltrate 600 with D, Calcium/Vitamin D, Os-Cal 500 with D, Oysco 500 with D, Oyster Shell Calcium, Citracal + D, Calcium 600 D, Calcet, Calcarb with D, Citracal Creamy Bites, Os-Cal with D, Sedecal D, Dical Captabs, Oyster Shell Calcium with Vitamin D, Dicalphos plus D, Oysco D with Calcium, Citracal Regular

Screen Teens With Depression for Heart Disease, Experts Say

Posted 11 Aug 2015 by

TUESDAY, Aug. 11, 2015 – Teens with major depression or bipolar disorder may face a higher risk for heart disease and they need to be followed closely, new recommendations from the American Heart Association state. "Youth with mood disorders are not yet widely recognized as a group at increased risk for excessive and early heart disease. We hope these guidelines will spur action from patients, families and health care providers to reduce the risk of cardiovascular disease among these youth," Dr. Benjamin Goldstein, a child-adolescent psychiatrist at Sunnybrook Health Sciences Center at the University of Toronto, said in a heart association news release. Goldstein and his colleagues reviewed published studies and found that teens with major depression or bipolar disorder were more likely than other teens to have: high blood pressure; high cholesterol; obesity, especially around the ... Read more

Related support groups: Depression, High Blood Pressure, Bipolar Disorder, Obesity, Diabetes, Type 2, Hypertension, Smoking, Heart Disease, Major Depressive Disorder, High Cholesterol, Angina, Dysthymia, Cardiovascular Risk Reduction, Ischemic Heart Disease

New Drug Lowers Levels of Triglyceride Blood Fats: Study

Posted 29 Jul 2015 by

WEDNESDAY, July 29, 2015 – An experimental drug dramatically lowers blood levels of potentially harmful triglycerides, a new study finds. Triglycerides are a type of blood fat created by the food you eat. At very high levels, they can cause heart problems and pancreatitis, an inflammation of the pancreas. "Current treatment for elevated triglyceride [levels] leaves a lot to be desired," said researcher Dr. Joseph Witztum, a professor of medicine at the University of California, San Diego. "This drug holds the promise that it will be the most effective therapy we have." The new drug – called ISIS 304801 for now – lowers triglyceride levels by as much as 71 percent without unpleasant side effects, the study found. Elevated triglycerides can be caused by genetics as well as obesity, smoking, drinking too much alcohol and a diet very high in carbohydrates, the American Heart Association ... Read more

Related support groups: High Cholesterol, Hypertriglyceridemia, Cardiovascular Risk Reduction

FDA OKs Praluent - First of New Class of Cholesterol Drugs

Posted 27 Jul 2015 by

FRIDAY, July 24, 2015 – The U.S. Food and Drug Administration on Friday approved Praluent, the first of a powerful new class of injected, cholesterol-lowering drugs that experts believe could change cardiovascular care. Praluent (alirocumab) sharply cuts levels of LDL ("bad") cholesterol, and is one of a group of newly developed drugs called PCSK9 inhibitors, the FDA explained in a news release. The drug is only approved for patients with heart disease and a history of heart attack or stroke "who require additional lowering of LDL cholesterol" in addition to taking a statin drug and adopting a healthy diet, the agency said. It is also for use by patients with a condition called heterozygous familial hypercholesterolemia (HeFH), an inherited illness that causes people to have high levels of LDL in the blood. "Praluent provides another treatment option for patients with HeFH or with ... Read more

Related support groups: High Cholesterol, High Cholesterol - Familial Heterozygous, Praluent, Alirocumab

Praluent Approved to Treat High Cholesterol

Posted 27 Jul 2015 by

MONDAY, July 27, 2015 – Praluent (alirocumab) injection has been approved by the U.S. Food and Drug Administration to treat people with inherited high cholesterol (heterozygous familial hypercholesterolemia) or people at risk of heart attack or stroke from high cholesterol derived from foods or produced by the liver. The drug is sanctioned for people who do not benefit enough from improved diet and the use of cholesterol-lowering statins. Low-density lipoprotein (LDL, the so-called "bad cholesterol") is linked to cardiovascular disease. Heart disease is the leading cause of death among American men and women, killing some 610,000 people every year, the FDA said in a news release. Praluent is the first-approved drug in a new class of medications called proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors. The drug is an antibody that inhibits the PCSK9 protein, which allows ... Read more

Related support groups: High Cholesterol, High Cholesterol - Familial Heterozygous, Praluent, Alirocumab

Page 1 2 3 ... Next

Ask a Question

Further Information

Related Condition Support Groups

Hypertriglyceridemia, Hyperlipoproteinemia, High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Niacin Flush, Sitosterolemia

Related Drug Support Groups

Lipitor, simvastatin, Crestor, atorvastatin, pravastatin, niacin, Welchol, Zocor, Niaspan, view more... lovastatin, Zetia, Vytorin, gemfibrozil, rosuvastatin, garlic, green tea, evening primrose, Trilipix, Pravachol, Primrose Oil, Evening Primrose Oil, red yeast rice, Livalo, Lopid, mycophenolate mofetil, Simcor, Slo-Niacin, flax, ezetimibe, fenofibric acid, colesevelam, Lescol, Lescol XL, Mevacor, Flax Seed Oil, Advicor, Praluent, fluvastatin, Altoprev, Garlic Oil, Nicotinic Acid, pitavastatin, Nicotinex, Fibricor, HDL Benefit, Juvisync, Nico-400, ezetimibe / simvastatin, B-3-50, niacin / simvastatin, lovastatin / niacin, simvastatin / sitagliptin, alirocumab, garcinia (hydroxycitric acid), Niacor, Altocor, Niacor B3, B3-500-Gr, Nicobid Tempules, Nicolar, Niacin SR